199 related articles for article (PubMed ID: 11477145)
1. Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues.
Maillard M; Cadot B; Ball RY; Sethia K; Edwards DR; Perbal B; Tatoud R
Mol Pathol; 2001 Aug; 54(4):275-80. PubMed ID: 11477145
[TBL] [Abstract][Full Text] [Related]
2. The expression of ccn3(nov) gene in musculoskeletal tumors.
Manara MC; Perbal B; Benini S; Strammiello R; Cerisano V; Perdichizzi S; Serra M; Astolfi A; Bertoni F; Alami J; Yeger H; Picci P; Scotlandi K
Am J Pathol; 2002 Mar; 160(3):849-59. PubMed ID: 11891184
[TBL] [Abstract][Full Text] [Related]
3. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
4. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
[TBL] [Abstract][Full Text] [Related]
5. Nephroblastoma overexpressed gene (NOV) codes for a growth factor that induces protein tyrosine phosphorylation.
Liu C; Liu XJ; Crowe PD; Kelner GS; Fan J; Barry G; Manu F; Ling N; De Souza EB; Maki RA
Gene; 1999 Oct; 238(2):471-8. PubMed ID: 10570975
[TBL] [Abstract][Full Text] [Related]
6. The expression of ccn3 (nov) RNA and protein in the rat central nervous system is developmentally regulated.
Su BY; Cai WQ; Zhang CG; Martinez V; Lombet A; Perbal B
Mol Pathol; 2001 Jun; 54(3):184-91. PubMed ID: 11376133
[TBL] [Abstract][Full Text] [Related]
7. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues.
Perbal B
Mol Pathol; 2001 Apr; 54(2):57-79. PubMed ID: 11322167
[TBL] [Abstract][Full Text] [Related]
8. Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines.
Dahiya R; Lee C; Haughney PC; Chui R; Ho R; Deng G
Urology; 1996 Dec; 48(6):963-70. PubMed ID: 8973690
[TBL] [Abstract][Full Text] [Related]
9. A role for CCN3 (NOV) in calcium signalling.
Li CL; Martinez V; He B; Lombet A; Perbal B
Mol Pathol; 2002 Aug; 55(4):250-61. PubMed ID: 12147716
[TBL] [Abstract][Full Text] [Related]
10. NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia.
Yu C; Le AT; Yeger H; Perbal B; Alman BA
J Pathol; 2003 Dec; 201(4):609-15. PubMed ID: 14648665
[TBL] [Abstract][Full Text] [Related]
11. The over-expression of Pim-2 promote the tumorigenesis of prostatic carcinoma through phosphorylating eIF4B.
Ren K; Gou X; Xiao M; Wang M; Liu C; Tang Z; He W
Prostate; 2013 Sep; 73(13):1462-9. PubMed ID: 23813671
[TBL] [Abstract][Full Text] [Related]
12. Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury.
Ellis PD; Chen Q; Barker PJ; Metcalfe JC; Kemp PR
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1912-9. PubMed ID: 10938011
[TBL] [Abstract][Full Text] [Related]
13. Expression of c-erb B-2/neu proto-oncogene in human prostatic cancer tissues and cell lines.
Zhau HE; Wan DS; Zhou J; Miller GJ; von Eschenbach AC
Mol Carcinog; 1992; 5(4):320-7. PubMed ID: 1353965
[TBL] [Abstract][Full Text] [Related]
14. Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors.
Doghman M; Arhatte M; Thibout H; Rodrigues G; De Moura J; Grosso S; West AN; Laurent M; Mas JC; Bongain A; Zambetti GP; Figueiredo BC; Auberger P; Martinerie C; Lalli E
J Clin Endocrinol Metab; 2007 Aug; 92(8):3253-60. PubMed ID: 17566092
[TBL] [Abstract][Full Text] [Related]
15. c-met proto-oncogene expression in benign and malignant human prostate tissues.
Pisters LL; Troncoso P; Zhau HE; Li W; von Eschenbach AC; Chung LW
J Urol; 1995 Jul; 154(1):293-8. PubMed ID: 7539865
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and genotypic characterization of commonly used human prostatic cell lines.
Mitchell S; Abel P; Ware M; Stamp G; Lalani E
BJU Int; 2000 May; 85(7):932-44. PubMed ID: 10792179
[TBL] [Abstract][Full Text] [Related]
17. Expression, localisation and potential significance of aquaporins in benign and malignant human prostate tissue.
Bründl J; Wallinger S; Breyer J; Weber F; Evert M; Georgopoulos NT; Rosenhammer B; Burger M; Otto W; Rubenwolf P
BMC Urol; 2018 Sep; 18(1):75. PubMed ID: 30176851
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
[TBL] [Abstract][Full Text] [Related]
20. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
